NL7308267A - - Google Patents

Info

Publication number
NL7308267A
NL7308267A NL7308267A NL7308267A NL7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A NL 7308267 A NL7308267 A NL 7308267A
Authority
NL
Netherlands
Application number
NL7308267A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7308267A publication Critical patent/NL7308267A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL7308267A 1972-06-15 1973-06-14 NL7308267A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2811872A GB1434919A (en) 1972-06-15 1972-06-15 3alpha-hydroxy androstanes

Publications (1)

Publication Number Publication Date
NL7308267A true NL7308267A (en) 1973-12-18

Family

ID=10270562

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7308267A NL7308267A (en) 1972-06-15 1973-06-14

Country Status (9)

Country Link
BE (1) BE800899R (en)
CA (1) CA1040619A (en)
DE (1) DE2330342A1 (en)
DK (1) DK136157B (en)
FR (1) FR2189034B2 (en)
GB (1) GB1434919A (en)
LU (1) LU67790A1 (en)
NL (1) NL7308267A (en)
ZA (1) ZA734037B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2909546C (en) 2013-04-17 2019-01-22 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
KR102396328B1 (en) 2013-04-17 2022-05-10 세이지 테라퓨틱스, 인크. 19-nor c3,3-disubstituted c21-n-pyrazolyl steroids and methods of use thereof
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
EP3868382A1 (en) 2013-07-19 2021-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
DK3488852T3 (en) 2013-08-23 2021-02-01 Sage Therapeutics Inc NEUROACTIVE STEROIDS, COMPOSITIONS AND USES
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
SI3206493T1 (en) 2014-10-16 2020-10-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3206494A4 (en) 2014-10-16 2018-07-04 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
PL3224269T3 (en) 2014-11-27 2020-08-24 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
SI3250210T1 (en) 2015-01-26 2021-07-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
WO2018013615A1 (en) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
MA45599A (en) 2016-07-11 2019-05-15 Sage Therapeutics Inc NEUROACTIVE STEROIDS SUBSTITUTED FOR C17, C20 AND C21 AND THEIR USE PROCEDURES
PE20230244A1 (en) 2019-05-31 2023-02-07 Sage Therapeutics Inc NEUROACTIVE STEROIDS AND COMPOSITIONS THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH273860A (en) * 1942-04-25 1951-02-28 Nv Organon Process for the preparation of a compound of the cyclopentanopolyhydrophenanthrene series which contains an oxygen-containing group in ring C.
GB1380246A (en) * 1970-12-17 1975-01-08 Glaxo Lab Ltd 3alpha-hydroxy-androstanes and esters thereof
FR2118117B1 (en) * 1970-12-17 1975-12-26 Glaxo Lab Ltd

Also Published As

Publication number Publication date
GB1434919A (en) 1976-05-12
DE2330342A1 (en) 1974-01-17
DK136157C (en) 1978-01-23
LU67790A1 (en) 1973-08-16
ZA734037B (en) 1974-05-29
DK136157B (en) 1977-08-22
BE800899R (en) 1973-12-14
AU5693773A (en) 1974-12-19
FR2189034A2 (en) 1974-01-25
FR2189034B2 (en) 1977-01-21
CA1040619A (en) 1978-10-17

Similar Documents

Publication Publication Date Title
FR2189034B2 (en)
AU465394B2 (en)
JPS5331849B2 (en)
JPS4940658A (en)
DK137365C (en)
JPS4927017A (en)
JPS4966706U (en)
JPS5420470Y2 (en)
JPS4883344U (en)
JPS4952971U (en)
JPS4983440A (en)
JPS4887926U (en)
JPS4967904U (en)
JPS488248U (en)
BG18542A1 (en)
CH565350A5 (en)
CH560012A5 (en)
CH560090A5 (en)
CH560097A5 (en)
CH561007A5 (en)
CH560040A5 (en)
CH563795A5 (en)
CH563885A5 (en)
CH563909A5 (en)
CH1320272A4 (en)

Legal Events

Date Code Title Description
BV The patent application has lapsed